CIK 0001384101
- Large accelerated filer
VERACYTE, INC.
Sign in to watch- Ticker
- VCYT
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 205455398
- Phone
- +1 650-243-6300
- Business address
- 6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- CALDEROME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,858,989
- in 9 filings, $2.9M under 10b5-1 plans
Net −$2,858,989. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −2,477 | $42.81 | $106K | 167,200 |
| 2026-09-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −1,175 | $43.71 | $51K | 166,025 |
| 2026-09-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes 10b5-1 | −3,603 | $44.88 | $162K | 169,677 |
| 2026-06-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −1,600 | $49.28 | $79K | 175,241 |
| 2026-06-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −1,961 | $50.09 | $98K | 173,280 |
| 2026-06-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes 10b5-1 | −3,693 | $47.80 | $177K | 176,841 |
| 2026-03-06 | Chambers Rebecca Chief Financial Officer | Grant or award | +36,181 | 167,377 | ||
| 2026-03-06 | Chambers Rebecca Chief Financial Officer | Grant or award | +13,157 | 180,534 | ||
| 2026-03-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −4,400 | $35.55 | $156K | 145,137 |
| 2026-03-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −13,941 | $36.33 | $506K | 131,196 |
| 2026-03-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes | −7,234 | $36.01 | $260K | 149,537 |
| 2026-02-26 | Chambers Rebecca Chief Financial Officer | Grant or award | +59,324 | 168,820 | ||
| 2026-02-26 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes | −12,049 | $38.75 | $467K | 156,771 |
| 2025-12-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −8,537 | $46.61 | $398K | 114,237 |
| 2025-12-04 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −4,741 | $47.25 | $224K | 109,496 |
| 2025-12-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes 10b5-1 | −3,384 | $46.16 | $156K | 122,774 |
| 2025-11-05 | Chambers Rebecca Chief Financial Officer | Sale 10b5-1 | −7,000 | $41.00 | $287K | 126,158 |
| 2025-09-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes | −5,371 | $30.11 | $162K | 133,158 |
| 2025-06-02 | Chambers Rebecca Chief Financial Officer | Shares withheld for taxes | −5,370 | $26.74 | $144K | 138,529 |
| 2025-03-06 | Chambers Rebecca Chief Financial Officer | Grant or award | +30,200 | 143,899 |
Page 1 of 2 · 35 trades